VICAPSYN Trademark

Trademark Overview

On Thursday, September 14, 2017, a trademark application was filed for VICAPSYN with the United States Patent and Trademark Office. The USPTO has given the VICAPSYN trademark a serial number of 87608595. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 11, 2019. This trademark is owned by ViCapsys, Inc.. The VICAPSYN trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical or clinical use, namely, implantable and insulin producing pancreatic cells
vicapsyn

General Information

Serial Number87608595
Word MarkVICAPSYN
Filing DateThursday, September 14, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 11, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2018

Trademark Statements

Goods and ServicesCells for medical or clinical use, namely, implantable and insulin producing pancreatic cells

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 20, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameViCapsys, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCumming, GA 30041
Party NameViCapsys, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCumming, GA 30041

Trademark Events

Event DateEvent Description
Tuesday, November 12, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 11, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, April 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 10, 2019EXTENSION 2 GRANTED
Wednesday, April 10, 2019EXTENSION 2 FILED
Wednesday, April 10, 2019TEAS EXTENSION RECEIVED
Thursday, October 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 9, 2018EXTENSION 1 GRANTED
Tuesday, October 9, 2018EXTENSION 1 FILED
Tuesday, October 9, 2018TEAS EXTENSION RECEIVED
Tuesday, April 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 5, 2018ASSIGNED TO LIE
Wednesday, December 20, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 20, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, December 20, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 20, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, December 20, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 19, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, December 19, 2017PRIORITY ACTION E-MAILED
Tuesday, December 19, 2017PRIORITY ACTION WRITTEN
Tuesday, December 19, 2017ASSIGNED TO EXAMINER
Wednesday, September 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 18, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

vicapsyn cells producing pancreatic insulin namely medical clinical implantable